Related Experiment Videos
Vascular endothelial growth factor and its receptors
Progress in Growth Factor Research
|January 1, 1994
Summary
Vascular endothelial growth factor (VEGF) is crucial for blood vessel formation and permeability. Antibodies targeting VEGF can inhibit tumor growth, highlighting its role in angiogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and vascular permeability.
- VEGF exhibits structural similarity to platelet-derived growth factor (PDGF).
- Alternative splicing of a single gene generates five VEGF mRNA variants with distinct properties.
Purpose of the Study:
- To investigate the role of VEGF in tumor angiogenesis.
- To explore the function of VEGF receptors on various cell types.
- To characterize the interaction of VEGF165 with its receptors.
Main Methods:
- Analysis of VEGF mRNA variants and protein expression.
- Use of antibodies against VEGF to inhibit tumor growth.
- Investigation of VEGF receptor binding and signaling pathways.
Main Results:
- VEGF is produced by both normal and tumor cells, playing a significant role in tumor angiogenesis.
- Antibodies against VEGF demonstrate efficacy in inhibiting the growth of VEGF-producing tumors.
- VEGF165, a well-characterized form, binds to heparin-like molecules on endothelial cells.
- Tyrosine-kinase receptors encoded by flt and KDR/flk-1 genes function as VEGF165 receptors.
Conclusions:
- VEGF is a critical factor in tumor angiogenesis and a potential therapeutic target.
- Understanding VEGF-receptor interactions is essential for developing anti-angiogenic therapies.
- Further research is needed to elucidate the function of VEGF receptors in non-proliferating cells.